Skip to main content

DEUTSCHE BANK AG\

Bank

Position in TRVI — Trevi Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in TRVI

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$2,135,181
+$1,124,055 QoQ
Shares Held
114,487
+35.1% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 216 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. TRVI ranks #109 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRVI

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,135,181 114,487
2026-03-31 $1,011,126 84,755
2025-12-31 $886,828 70,833
2025-09-30 $472,505 51,640
2025-06-30 $237,599 43,437
2025-03-31 $236,666 37,626
2024-12-31 $120,480 29,243
2024-09-30 $95,383 28,558
2024-06-30 $41,490 13,923
2024-03-31 $61,468 17,817
2023-09-30 $54,651 25,070